Skip to main content
. 2019 May 30;5(5):e01761. doi: 10.1016/j.heliyon.2019.e01761

Fig. 3.

Fig. 3

Effects of PZM on the activities of ALT (A) and AST (B) in serum against CCl4-induced hepatoxicity in mice. Group I: normal control; group II: PZM control; group III: model; group IV: Silymarin-treated; group V: PZ-treated; group VI: PZM-treated (20 mg/kg); group VII: PZM-treated (40 mg/kg), group VIII: PZM-treated (80 mg/kg). Values are expressed as mean ± SD.P < 0.05, ∗∗P < 0.01 compared to normal group. +P < 0.05, ++P < 0.01 compared to model group.